SYDNEY — On Friday, Challenger spent A$4.9 million buying back 500,000 of its own shares at prices between A$9.69 and A$9.89. After the market closed, an offer of A$11.80 a share arrived.
The bidder is TAL Daiichi Life Australia, a unit of Japan’s Daiichi Life Group, which wants the 79.5 percent of the retirement-income provider it does not own. Challenger told the ASX at 21:01 UTC on Sunday, 8:01 a.m. Monday in Sydney, according to the exchange’s announcements feed, that its board is considering the indicative offer and shareholders need take no action.
The proposal is non-binding. It depends on due diligence, a scheme implementation agreement, approval from “various regulatory bodies” and a board recommendation, and Challenger warned there is “no certainty the proposal will result in a binding offer.” The price is the live question. Challenger frames A$11.80 as 17.7 percent above its one-month average of A$10.03; against Friday’s A$9.85 close in ASX data it is 19.8 percent, by TEH’s arithmetic.
TAL’s history is a second yardstick. In April 2025 it agreed to buy a 15.1 percent stake from MS&AD at ¥763 a share, about A$8.46, which Challenger said in an April 2025 release was a 53 percent premium to the prior close. The new price is 39.5 percent higher. Challenger’s market release on the offer gives no figure for TAL’s current holding; subtracting 79.5 from 100 implies about 20.5 percent. On the 675.6 million shares ASX data shows on issue, A$11.80 values the company near A$8.0 billion and the part TAL lacks near A$6.3 billion. Those are TEH’s figures, and the buy-back keeps moving the share count.
Challenger’s quarter landed the same morning. Its first-quarter update reported assets under management up 5 percent to A$31.9 billion and total sales up 52 percent to A$4.4 billion, and chief executive Nick Hamilton said the company has “started the year strongly.” The sales jump leans on one deal. Fixed-term sales rose 103 percent, driven partly by an inaugural A$750 million three-year note; if all of it counts as sales, total sales excluding it were up about 26 percent. The release credits long fixed terms to “the higher rate environment,” after the Reserve Bank’s fourth rate rise, and offshore reinsurance sales rose 30 percent on “strong demand for Yen-denominated annuities in Japan.” The funds arm Fidante saw funds under management fall 5 percent to A$85 billion on A$3.3 billion of net outflows.
By late morning in Sydney the shares traded near A$11.24, up about 14 percent but roughly 5 percent under the offer. Nobody has said whether that gap reflects doubt about completion or hope of a higher bid. Nor has Challenger said whether it will keep buying back stock. On Friday it paid about A$9.84 a share. Its filing says only that it “retains the ability to vary, pause or terminate at any time.”
